Prostate Cancer

REVIEW UroToday

A Phase I Trial of Image-Guided, Risk-Volume-Adapted Post-Prostatectomy Radiotherapy - Beyond the Abstract October 31, 2024

How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial - Beyond the Abstract October 22, 2024

Sequential [177Lu]Lu-PSMA-617 and Docetaxel Versus Docetaxel in Patients with Metastatic Hormone-Sensitive Prostate Cancer (UpFrontPSMA): A Multicentre, Open-Label, Randomised, Phase 2 Study - Beyond the Abstract October 22, 2024

Prostate Cancer Early Detection in the European Union and UK - Beyond the Abstract October 18, 2024

Local Salvage Therapies in Patients with Radio-Recurrent Prostate Cancer Following External Beam Radiotherapy: A Systematic Review and Meta-Analysis - Beyond the Abstract October 18, 2024

A Targeted Methylation-Based Multicancer Early Detection Blood Test Preferentially Detects High-Grade Prostate Cancer While Minimizing Overdiagnosis of Indolent Disease - Beyond the Abstract October 18, 2024

Gastrin Releasing Peptide Receptors-targeted PET Diagnostics and Radionuclide Therapy for Prostate Cancer Management - Beyond the Abstract October 17, 2024

Prediction of Undetectable Circulating Tumor DNA by Comprehensive Genomic Profiling Assay in Metastatic Prostate Cancer: The SCRUM-Japan MONSTAR SCREEN Project - Beyond the Abstract October 16, 2024

Survival of Men with Metastatic Hormone-Sensitive Prostate Cancer and Adrenal-Permissive HSD3B1 Inheritance - Beyond the Abstract October 15, 2024

Multiplex Imaging of Localized Prostate Tumors Reveals Altered Spatial Organization of AR-Positive Cells in the Microenvironment - Beyond the Abstract October 9, 2024

The Man Van: A Pilot Study of Using Mobile Targeted Case-Finding to Address Health Inequalities in Prostate Cancer - Beyond the Abstract October 8, 2024

Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial - Beyond the Abstract October 8, 2024

Impact of a Rash Management Guide in Patients Receiving Apalutamide for High-Risk Localized Prostate Cancer in the Apa-RP Study - Beyond the Abstract October 7, 2024

Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer - Beyond the Abstract October 3, 2024

Prospective Comparison of 68Ga-NeoB and 68Ga-PSMA-R2 PET/MRI in Patients with Biochemically Recurrent Prostate Cancer - Beyond the Abstract September 26, 2024

Identifying Barriers to Timely Follow-up After Elevated PSA Screening: A Retrospective Analysis of a Large Healthcare System - Beyond the Abstract September 25, 2024

Cost-Utility Analysis of Navigate, a Treatment Decision Aid for Men with Prostate Cancer and Their Partners, in Comparison to Usual Care - Beyond the Abstract September 25, 2024

Neurologic Symptoms after 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience - Beyond the Abstract September 25, 2024

5-α Reductase Inhibitors and Prostate Cancer Mortality - Beyond the Abstract September 20, 2024

Racial, Ethnic, and Socioeconomic Disparities in Rates of Stage IV Prostate Cancer After USPSTF Category "D" Recommendation Against Prostate-Specific Antigen Screening: A Retrospective Cohort Study - Beyond the Abstract September 11, 2024

Page 1 of 57